CDK6 siRNAs were transfected in HMC1.1, a mast-cell leukemia carrying an endogenous point mutation in the juxtamembrane domain of KIT, and TF-1 cells stably transfected with the classical KIT D816V mutation. The gene discussed is CDK6; the disease is mast cell leukemia.